by Mesencell Biotech GmbH
Saint Gallen
Entwicklung eines Speicheltestes zur Früherkennung der Alzheimer Krankheit.
CHF 200
5% of CHF 3’500
The «all or nothing» principle applies: The project only receives the funds if the funding target is reached or exceeded.
2 backers
Concluded on 26/12/2016
